News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-07 11:56:44 am FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Beats Revenue for Q4 2023 InvestorPlace
2024-03-07 5:20:5 am Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Tops Revenue Estimates Zacks
2024-03-07 4:0:0 am Foghorn Therapeutics Provides Financial Update for 2023 and 2024 Strategic Outlook GlobeNewswire
2024-03-05 1:48:0 pm Foghorn Therapeutics to Present New Preclinical Data at 2024 AACR Annual Meeting, Reflecting Advances with Multiple Potential First-in-Class Medicines, including the Selective Inhibitor of BRM, FHD-909 GlobeNewswire
2024-02-28 5:29:0 am Silence Therapeutics PLC Sponsored ADR (SLN) Soars 6.4%: Is Further Upside Left in the Stock? Zacks
2024-02-28 4:0:0 am Foghorn Therapeutics to Participate in Cowen’s 44th Annual Health Care Conference GlobeNewswire
2024-02-11 11:43:0 pm Foghorn Therapeutics Inc. (FHTX) Moves 22.7% Higher: Will This Strength Last? Zacks
2024-02-09 7:2:0 am Foghorn (FHTX) Jumps 55% as Lilly Takes Up FHD-909 Development Zacks
2024-02-08 4:0:0 am Foghorn Provides Pipeline Update on FHD-909 BRM Selective Inhibitor GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information